|
|
View Clinical Trial (Medical Research Study)
|
Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial - NCT01003496-43207 (Clinical Trial 385639)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy385639.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Columbus |
|
State:
|
|
OH |
| Zip Code: |
|
43207 |
| Conditions: |
|
Drug Addiction |
| Purpose: |
|
The purpose of this 2 year study is to conduct a fully powered effectiveness trial comparing
recovery trajectories of 200 drug dependent adults (the subjects) who will be randomly
assigned to Treatment as Usual (TAU) or TAU + Long-Term Recovery Management (LTRM).
|
| Study summary: |
|
Drug addiction is a chronic illness characterized by problematic drug use, followed by
periods of abstinence, reductions in use, or return to problematic drug use. Despite this,
substance abuse treatment has traditionally been based on an acute care model. The field
needs an addiction management model for drug-dependent patients, which, like disease
management for other chronic conditions, provides: 1) initial stabilization; 2) ongoing
treatment to maintain clinical gains; 3) monitoring of patient symptoms; and 4) adjustments
to the treatment based on the patient's response.
In response to these needs we have developed the Long Term Recovery Management (LTRM) model.
LTRM is predicated on initiating long-term addiction management at the onset of substance
abuse treatment, extending the length of treatment, expediting the transitions between
intensive treatment and maintenance of behavioral change, adapting treatment intensity to
patient's response to treatment, and actively facilitating the therapeutic alliance. LTRM
combines 3 established treatment techniques (Community Reinforcement Approach, Contingency
Management, and Facilitated Therapeutic Alliance), each with demonstrated efficacy, into a
chronic disease model. In addition, patient cases are kept open, thereby removing potential
obstacles to re-engagement with stepped-up care, when indicated. The LTRM model emphasizes:
engagement in continuous long-term treatment and recovery support, therapeutic alliance, and
early re-intervention as the main mechanisms for maintenance of behavioral change. |
| Criteria: |
|
Inclusion Criteria:
To be eligible for the study, a subject must:
- At least 18 years of age
- Meet current dependence criteria for stimulants (cocaine/other), opioids
(heroin/other), and/or alcohol (if also dependent on cocaine or opioids). Persons who
are opioid dependent are eligible if they are not in methadone maintenance therapy;
they will be eligible if they are in short-term buprenorphine detoxification
- Self-report use of a primary drug of dependence in the past 60 days; 4) be admitted
to outpatient care at Maryhaven
- Willing to participate in the protocol (i.e., to be randomized to treatment condition
and agree to attend regular treatment sessions).
Exclusion Criteria:
- Potential subjects will be excluded if they: 1) present with current suicide risk
- Have a current, untreated psychotic disorder
- Plan to relocate outside of the area within 12 months
- Have been sentenced to incarceration of more than 30 days over the next 6 months
- Are alcohol dependent without current dependence on cocaine or opioids. |
|
|
|
| Study is available at: |
|
Maryhaven
Columbus, OH 43207
United States
Primary Contact:
Gregory S. Brigham, Ph.D.
Email: gbrigham@maryhaven.com
Phone: 614-445-8131
Secondary Contact:
Robert G. Carlson, Ph.D.
Email: robert.carlson@wright.edu
Phone: 937-775-2066 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|
|
|
|